Dimensional Fund Advisors LP Sells 13,686 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI)

Dimensional Fund Advisors LP reduced its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,305,970 shares of the medical instruments supplier’s stock after selling 13,686 shares during the quarter. Dimensional Fund Advisors LP owned about 2.25% of Merit Medical Systems worth $112,243,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of MMSI. Opal Wealth Advisors LLC bought a new stake in Merit Medical Systems during the 2nd quarter valued at $29,000. Parallel Advisors LLC raised its position in Merit Medical Systems by 114.6% during the 4th quarter. Parallel Advisors LLC now owns 397 shares of the medical instruments supplier’s stock valued at $30,000 after purchasing an additional 212 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new stake in Merit Medical Systems during the 1st quarter valued at $44,000. Headlands Technologies LLC bought a new stake in Merit Medical Systems during the 1st quarter valued at $50,000. Finally, EntryPoint Capital LLC raised its position in Merit Medical Systems by 2,666.7% during the 1st quarter. EntryPoint Capital LLC now owns 913 shares of the medical instruments supplier’s stock valued at $69,000 after purchasing an additional 880 shares in the last quarter. 99.66% of the stock is owned by institutional investors.

Insider Buying and Selling at Merit Medical Systems

In other Merit Medical Systems news, Director F. Ann Millner sold 12,500 shares of the business’s stock in a transaction dated Friday, June 28th. The stock was sold at an average price of $85.00, for a total transaction of $1,062,500.00. Following the sale, the director now owns 32,391 shares in the company, valued at approximately $2,753,235. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 3.70% of the company’s stock.

Merit Medical Systems Stock Up 0.4 %

Shares of MMSI stock opened at $100.00 on Tuesday. Merit Medical Systems, Inc. has a 1-year low of $62.58 and a 1-year high of $101.60. The stock’s fifty day moving average price is $92.01 and its 200 day moving average price is $83.39. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.24 and a quick ratio of 4.64. The company has a market cap of $5.81 billion, a price-to-earnings ratio of 57.47, a price-to-earnings-growth ratio of 2.53 and a beta of 0.87.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.04. The business had revenue of $338.00 million for the quarter, compared to the consensus estimate of $334.94 million. Merit Medical Systems had a return on equity of 15.29% and a net margin of 9.02%. On average, research analysts expect that Merit Medical Systems, Inc. will post 3.31 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Barrington Research lifted their target price on Merit Medical Systems from $100.00 to $114.00 and gave the company an “outperform” rating in a research report on Friday. Robert W. Baird began coverage on Merit Medical Systems in a research report on Friday, June 28th. They issued an “outperform” rating and a $96.00 price target for the company. Piper Sandler reissued an “overweight” rating and issued a $110.00 price target (up from $100.00) on shares of Merit Medical Systems in a research report on Monday, September 9th. StockNews.com lowered Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Wednesday, September 18th. Finally, Bank of America boosted their price target on Merit Medical Systems from $92.00 to $103.00 and gave the stock a “neutral” rating in a research report on Monday, September 16th. Three research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $101.82.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.